What will it take to promote vaccine development in Africa?

Published Date: 02 Mar 2023

The COVID-19 pandemic has highlighted the importance of vaccines in controlling the epidemic in sub-Saharan Africa and a renewed interest in vaccine research and development across the country.

Read Full News

Latest News

New Parameters for Faster Geographic Atrophy Progression Established, with Srinivas Sadda, MD Srinivas Sadda, MD

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

OCU-410 Gene Therapy Preserves Visual Acuity and Slows GA Lesion Progression, with Jay Chhablani, MD Jay Chhablani, MD

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Intravitreal UBX1325 Shows Efficacy in Diabetic Retinopathy, DME, with Dante Pieramici, MD Dante J. Pieramici, MD

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

Q3 2025 Recap: Ophthalmology News and Updates Ryan Livingston

The Q3 recap for ophthalmology spotlights major FDA decisions and major clinical trial updates in a variety of diseases.

Psoriasis Associated with Risk of Age-Related Macular Degeneration Ryan Livingston

Based on 3 propensity-matched control groups, patients with psoriasis can have anywhere from a 40% to 56% higher risk.

Correlation Between Diabetes and Risk of Uveitis Confirmed in Recent Study Ryan Livingston

In addition to type 1 and 2 diabetes, diabetic retinopathy substantially increases the risk of developing and worsening uveitis.

Todays Updates

FDA Reverses Course on AMT-130, Citing Insufficient External Data for Submission Marco Meglio

uniQure navigates FDA's unexpected shift on AMT-130, aiming for accelerated approval for Huntington's disease despite recent regulatory challenges.

Episode 155: Understanding Variability in Infantile Spasms Care Marco Meglio, Christina Briscoe, MD

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Christina Briscoe, MD. [LISTEN TIME: 24 minutes]

Real-World Meta-Analysis Confirms Efficacy and Safety of CGRP Treatment Galcanezumab in Migraine Isabella Ciccone, MPH

Over the first 3 months of treatment, over 60% of patients with migraine treated with galcanezumab attained at least a 50% reduction in monthly migraine or headache days.

NeurologyLive® Friday 5 — November 28, 2025 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 28, 2025.

Sparsentan's Effect on Urinary Biomarkers in IgAN, With Chee Kay Cheung, MBChB, PhD Chee Kay Cheung, MBChB, PhD

Cheung explores the effect of sparsentan on urinary biomarkers in treatment-naive patients with IgA nephropathy.

ACR Convergence 2025 Recap: Late-Breaking Trials to Know

ACR Convergence 2025 Recap: Late-Breaking Trials to Know

Tezepelumab Drastically Reduces OCS Use for Asthma in Open-Label Trial

Tezepelumab Drastically Reduces OCS Use for Asthma in Open-Label Trial

Todays Updates

FDA Reverses Course on AMT-130, Citing Insufficient External Data for Submission Marco Meglio

uniQure navigates FDA's unexpected shift on AMT-130, aiming for accelerated approval for Huntington's disease despite recent regulatory challenges.

Episode 155: Understanding Variability in Infantile Spasms Care Marco Meglio, Christina Briscoe, MD

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Christina Briscoe, MD. [LISTEN TIME: 24 minutes]

Real-World Meta-Analysis Confirms Efficacy and Safety of CGRP Treatment Galcanezumab in Migraine Isabella Ciccone, MPH

Over the first 3 months of treatment, over 60% of patients with migraine treated with galcanezumab attained at least a 50% reduction in monthly migraine or headache days.

NeurologyLive® Friday 5 — November 28, 2025 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 28, 2025.

Sparsentan's Effect on Urinary Biomarkers in IgAN, With Chee Kay Cheung, MBChB, PhD Chee Kay Cheung, MBChB, PhD

Cheung explores the effect of sparsentan on urinary biomarkers in treatment-naive patients with IgA nephropathy.

ACR Convergence 2025 Recap: Late-Breaking Trials to Know

ACR Convergence 2025 Recap: Late-Breaking Trials to Know

Tezepelumab Drastically Reduces OCS Use for Asthma in Open-Label Trial

Tezepelumab Drastically Reduces OCS Use for Asthma in Open-Label Trial

Latest News

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

The Q3 recap for ophthalmology spotlights major FDA decisions and major clinical trial updates in a variety of diseases.

Based on 3 propensity-matched control groups, patients with psoriasis can have anywhere from a 40% to 56% higher risk.

In addition to type 1 and 2 diabetes, diabetic retinopathy substantially increases the risk of developing and worsening uveitis.

News All Time

Eye scans reveal clues to aging and heart disease risk, study finds

The tiny blood vessels in your eyes might hold the key to predicting a person's risk of developing heart disease and how fast they're biologically aging, according to researchers at McMaster University and Population Health ...

LASIK armed with 3D eye model provides better vision correction

An advanced form of LASIK (Laser-Assisted In-Situ Keratomileusis) eye surgery that uses a virtual 3D model of a person's eye appears to offer patients better vision, a new study says.

Fancy dress contact lenses can cause infections, ulcers, even blindness—how to keep your eyes safe this Halloween

With Halloween just around the corner, thousands will be shopping for fancy dress contact lenses to go with their costume. The appeal is clear, as their endless colors and shapes allow you to radically change how you look—who ...

Cataract surgery becoming an in-office procedure, experts say

Imagine popping by your eye doctor's office for a quick cataract surgery.

Age-related macular degeneration: Robot delivers ultra-precision injections with rapid setup times

Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex preparation required for robotic surgery still takes far too long. But a new robotic assistant for ...

Risk of eye disease increases during menopause transition

Many symptoms, such as hot flashes and vaginal dryness, are commonly associated with the menopause transition. One of the lesser-known symptoms that worsens in midlife is dry eyes. A new study suggests that postmenopausal ...

Like radar, a brain wave sweeps a cortical region to read out information held in working memory

Imagine you are a security guard in one of those casino heist movies where your ability to recognize an emerging crime will depend on whether you notice a subtle change on one of the many security monitors arrayed on your ...

Transformative eye research expands donor pool for corneal transplant patients

Many eye banks won't accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail.

Pickleball popularity surge serves up spike in serious eye injuries

Rutgers New Jersey Medical School-led researchers have identified a striking rise in pickleball-related eye injuries among players visiting emergency departments across the United States. Using two decades of national surveillance ...

Patient wealth is associated with quality of glaucoma care

Patients with newly diagnosed glaucoma who have less wealth or reside in rural communities are less likely to receive standard glaucoma care compared to wealthier patients, according to a recent multi-institutional study ...

Vision therapy reverses concussion-related double and blurred vision, study finds

Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from eye coordination disorders that cause double and blurred vision, headaches and difficulties concentrating.

FDA authorizes Essilor Stellest eyeglass lenses for children with myopia

The U.S. Food and Drug Administration has authorized marketing of the Essilor Stellest eyeglass lenses to correct myopia, with or without astigmatism, and to slow the progression of the disease in children 6 to 12 years old.

mRNA vaccine shows promise for treating age-related macular degeneration

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age-related macular degeneration ...

Bringing eye images into focus with AI

Researchers at the University of Waterloo have developed a better way to enhance the clarity and detail of eye images used to diagnose disease by teaching artificial intelligence (AI) software the science behind the imaging ...

Polyunsaturated fatty acid therapy reverses age-related vision decline in mice

Changes in vision are often a common sign of aging. But what if we could reverse age-related visual decline? In a new study, UC Irvine researchers explore a possible therapy for addressing "aging" in the eye and for preventing ...

AI at the eyelid: Glasses that track health through your blinks

Penn researchers have developed an AI-powered device that turns ordinary glasses into a smart, energy-efficient health monitor by watching you blink.

Recommended News For You

In a recent study, Kencur ginger's anti-cancer properties were discovered.

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

Breast density changes over time are associated with an increased risk of cancer.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

younger kidney cancer survivors are more susceptible to heart problems.

Recommended Articles For You

Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment 

Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results 

Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways 

AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Distribution of fat could influence cancer risk, study suggests

2.

Study looks into cancer-related harmful communication.

3.

Q&A: When will individuals be able to receive customized cancer vaccines?

4.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

5.

An Eye Surgeon's Unexpected Discovery of the "Before and After".

1.

Lymphomatoid Papulosis: What You Need to Know

2.

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options

3.

Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial

4.

Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy 

5.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

3.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

5.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot